menu
    • menu

    Company profile for Biosplice

    NEW Drugs in Dev: 6
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biosplice’s mission is to restore health by delivering first-in-class therapies that harness alternative splicing. Our scientific platform is based on biological discoveries that govern tissue specialization and enable us to selectively eliminate harmful proteins using small molecules. From our foundational discoveries in Want pathway modulation to unlocking the broad therapeutic potential of the CLK/DYRK target class, our ...
    Biosplice’s mission is to restore health by delivering first-in-class therapies that harness alternative splicing. Our scientific platform is based on biological discoveries that govern tissue specialization and enable us to selectively eliminate harmful proteins using small molecules. From our foundational discoveries in Want pathway modulation to unlocking the broad therapeutic potential of the CLK/DYRK target class, our focus is on the realization of new, potentially curative therapies for patients by selectively reprogramming cellular behavior.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiospliceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9360 Towne Centre Drive, San Diego, CA 92121
    Telephone
    Telephone
    +1 858 926 2900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biosplice.com/default.aspx
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biosplice Submits Lorecivivint NDA to FDA for Knee Osteoarthritis
    Biosplice Submits Lorecivivint NDA to FDA for Knee Osteoarthritis

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213418/0/en/Biosplice-Announces-the-Submission-of-its-New-Drug-Application-NDA-to-the-FDA-for-Lorecivivint-LOR-to-Treat-Knee-Osteoarthritis.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Biosplice Initiates Phase 1 Trial For Cirtuvivint And Olaparib
    Biosplice Initiates Phase 1 Trial For Cirtuvivint And Olaparib

    22 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/22/3209045/0/en/Biosplice-Therapeutics-Announces-First-Patient-Dosed-in-Investigator-Initiated-Phase-1-Clinical-Trial-of-Cirtuvivint-and-Olaparib-in-BRCA-HRD-Platinum-Resistant-Ovarian-Cancer.html

    GLOBENEWSWIRE
    22 Dec 2025
    Share Share
    1st Patient Dose in Trial of Biosplice's Cirtuvivint for Leukemia
    1st Patient Dose in Trial of Biosplice's Cirtuvivint for Leukemia

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146697/0/en/Biosplice-Therapeutics-Announces-First-Patient-Dosed-in-NCI-Sponsored-Clinical-Trial-of-Cirtuvivint-in-Acute-Myeloid-Leukemia-and-Myelodysplastic-Syndromes.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    Biosplice: First Patient Dosed in Phase 2 Trial of Cirtuvivint
    Biosplice: First Patient Dosed in Phase 2 Trial of Cirtuvivint

    01 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/01/3072165/0/en/Biosplice-Announces-First-Patient-Dosed-in-Phase-2-Trial-of-Cirtuvivint-for-Advanced-Soft-Tissue-Sarcomas.html

    GLOBENEWSWIRE
    01 May 2025
    Share Share
    Biosplice Initiates NCI-Sponsored AML And MDS Trial
    Biosplice Initiates NCI-Sponsored AML And MDS Trial

    12 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/12/2945069/0/en/Biosplice-Therapeutics-Announces-Initiation-of-Acute-Myeloid-Leukemia-AML-and-Myelodysplastic-Syndromes-MDS-Trial-Sponsored-by-the-National-Cancer-Institute-NCI.html

    GLOBENEWSWIRE
    12 Sep 2024
    Share Share
    Biosplice, Novo Nordisk Partner to Develop Drug for Treatment of Diabetes
    Biosplice, Novo Nordisk Partner to Develop Drug for Treatment of Diabetes

    13 Jun 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-06-13/biosplice-novo-nordisk-partner-to-develop-drug-candidates-for-treatment-of-diabetes/?widget=listSection

    CONTRACT PHARMA
    13 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search